Lili Miles, MD

Pathology

Primary Office

Nemours Children's Hospital, Florida Nemours Children's Hospital, Florida 6535 Nemours Parkway Orlando, FL 32827 Appointment: (407) 650-7715

Get to Know Me

In China, where I grew up, there were many patients but only a few doctors. I was determined to become a doctor to help the sick and vulnerable and to make a difference. I have dedicated myself to my patients. But for me, being a mother is the most important job of all. I love my own child unconditionally and want to treat all children like my own.

Why I Treat Children

I love children. My mother, a kindergarten teacher for 30 years, dedicated herself to helping young children. She had a strong influence on me. 

What I'm Passionate About

All children should receive high-quality medical care. I work to promote global health in the hope that children in this country and all over the world can have access to the best medical care.

How I Try to Make A Difference

I have been involved in the diagnosis and investigation of neuromuscular diseases, brain tumors, and intractable epilepsy disorders for many years. Seeing children suffering from those devastating diseases is very difficult. I believe that through medical research, we can make progress in finding cures.

Education & Training

Fellowship

  • Pediatric Pathology - Cincinnati Children's Hospital Medical Center, 2003
  • Surgical Pathology - Ohio State University Hospital, 2001

Internship

  • Obstetrics/Gynecology - International Peace Maternal/Child Health Hospital, 1987
  • Medicine - Ruijin Hospital, 1986

Residency

  • Pathology - University of Cincinnati Medical Center, 2001

Medical/Dental School

  • MD - Jiao Tong University, 1986

Board Certifications

  • American Board of Pathology/Pediatric Pathology
  • American Board of Pathology/Anatomic & Clinical Pathology

Insurance Accepted

  • Aetna Better Health FL Medicaid and Healthy Kids
  • Aetna Better Health PA Kids HMO
  • Aetna HMO
  • Aetna HMO/POS/PPO/EPO
  • Aetna PPO/POS/EPO
  • Alabama Medicaid/Patient First
  • AmeriHealth Caritas Florida (FKA Prestige Health Choice)
  • AvMed
  • Blue Cross and Blue Shield HMO
  • Blue Cross and Blue Shield Non HMO
  • Blue Cross Blue Shield Florida Blue Select
  • Carefirst MD Community Health Plan Mcaid
  • Cigna & Great West HMO/POS Open Access
  • Cigna & Great West PPO/EPO
  • Community Care Plan Medicaid
  • Employers Health Network PPO
  • Evolutions Healthcare
  • First Health Aetna PPO/EPO
  • First Health/Affordable PPO
  • Florida Medicaid
  • Florida Medicare
  • Geisinger Health Plan Commercial
  • Health First Health Plans
  • HEALTHSMART HLTH PLANS PPO ORL
  • HUMANA HEALTHY HORIZONS (FKA HUMANA MEDICAID)
  • Humana HMO/POS
  • Humana PPO/EPO
  • Independance Blue Cross/Amerihealth/Keystone Health Plan
  • Molina Healthcare Medicaid
  • Multiplan PPO
  • New Jersey Medicaid
  • Olympus Managed Healthcare PPO ORL
  • Pennsylvania Medicaid
  • Prime Health Services PPO Specialty Florida
  • Seminole Tribe of Florida
  • Simply Healthcare Healthy Kids
  • Simply Healthcare Medicaid HMO
  • Star Healthcare Network
  • Sunshine SMI/CMS 19 & 21
  • Sunshine State Health Plan Medicaid
  • Three Rivers Provider Network
  • Tricare/Humana Military Health Services
  • United Healthcare Commercial Products
  • United Healthcare Community Plan Medicaid
  • Volusia Health Network PPO/EPO
  • Wellpoint Maryland Medcaid

Research Activities

  • Pediatric brain tumors and intractable epilepsy disorders
  • Pediatric neuromuscular disease
  • Pediatric liver disease
  • Pediatric tumor

  • DeWire, M., Erker, C., Hummel, T. R., Chow, L. M. L., de Blank, P., Salloum, R., & Fouladi, M. (2021). Overcoming barriers to establishing autopsy procurement programs in pediatric patients with central nervous system tumors: a call to develop regional centers. Journal of Neuro-Oncology, 152(1), 107-114. doi:10.1007/s11060-020-03679-2

    View Full Publication
  • Ahluwalia, R., Miles, L., Hayes, L., & Scherer, A. (2020). Pediatric septal dysembryoplastic neuroepithelial tumor (sDNT): case-based update. Child's Nervous System, 36(6), 1127-1130. doi:10.1007/s00381-020-04581-y

    View Full Publication
  • Malik, F., Wang, L., Yu, Z., Edelman, M. C., Miles, L., Clay, M. R., & Bahrami, A. (2020). Benign infiltrative myofibroblastic neoplasms of childhood with USP6 gene rearrangement. Histopathology, 77(5), 760-768. doi:10.1111/his.14182

    View Full Publication
  • Williams, K. B., Brigatti, K. W., Puffenberger, E. G., Gonzaga-Jauregui, C., Griffin, L. B., Martinez, E. D., & Strauss, K. A. (2019). Homozygosity for a mutation affecting the catalytic domain of tyrosyl-tRNA synthetase (YARS) causes multisystem disease. Human Molecular Genetics, 28(4), 525-538. doi:10.1093/hmg/ddy344

    View Full Publication
  • Hoffman, L. M., Van Zanten, S. E. M. V., Colditz, N., Baugh, J., Chaney, B., Hoffmann, M., & Fouladi, M. (2018). Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A collaborative report from the International and European Society for Pediatric Oncology DIPG registries. Journal of Clinical Oncology, 36(19), 1963-1972. doi:10.1200/JCO.2017.75.9308

    View Full Publication
  • Anderson, J. L., Muraleedharan, R., Oatman, N., Klotter, A., Sengupta, S., Waclaw, R. R., & Dasgupta, B. (2017). The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas. Neuro-Oncology, 19(8), 1068-1078. doi:10.1093/neuonc/now299

    View Full Publication
  • Maynard, L. M., Leach, J. L., Horn, P. S., Spaeth, C. G., Mangano, F. T., Holland, K. D., & Greiner, H. M. (2017). Epilepsy prevalence and severity predictors in MRI-identified focal cortical dysplasia. Epilepsy Research, 132, 41-49. doi:10.1016/j.eplepsyres.2017.03.001

    View Full Publication
  • Bhattacharjee, J., Kirby, M., Softic, S., Miles, L., Salazar-Gonzalez, R.-M., Shivakumar, P., & Kohli, R. (2017). Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis. Hepatology Communications, 1(4), 299-310. doi:10.1002/hep4.1041

  • Salloum, R., Hummel, T. R., Kumar, S. S., Dorris, K., Li, S., Lin, T., & Drissi, R. (2016). A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study. Journal of Neuro-Oncology, 129(3), 443-451. doi:10.1007/s11060-016-2189-7

    View Full Publication

  • English
  • Chinese